SMN1 and proximal spinal muscular atrophy: Current methods for SMA diagnosis involve a multiple-step, time-consuming process, making use of SMN1 dosage tests (MLPA or quantitative PCR for copy number detection), followed by SMN1 sequencing when a heterozygous deletion is identified (Bai et al., 2024).